| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |